409 related articles for article (PubMed ID: 1661167)
1. Biology of the lymphomas: cytogenetics, molecular biology, and virology.
Ambinder RF; Griffin CA
Curr Opin Oncol; 1991 Oct; 3(5):806-12. PubMed ID: 1661167
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus and Burkitt's lymphoma.
Magrath I; Jain V; Bhatia K
Semin Cancer Biol; 1992 Oct; 3(5):285-95. PubMed ID: 1335792
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of activation and biological role of the c-myc oncogene in B-cell lymphomagenesis.
Dalla-Favera R; Lombardi L; Pelicci PG; Lanfrancone L; Cesarman E; Neri A
Ann N Y Acad Sci; 1987; 511():207-18. PubMed ID: 2830825
[No Abstract] [Full Text] [Related]
4. Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association.
Shiramizu B; Barriga F; Neequaye J; Jafri A; Dalla-Favera R; Neri A; Guttierez M; Levine P; Magrath I
Blood; 1991 Apr; 77(7):1516-26. PubMed ID: 1849033
[TBL] [Abstract][Full Text] [Related]
5. Molecular resemblance of an AIDS-associated lymphoma and endemic Burkitt lymphomas: implications for their pathogenesis.
Haluska FG; Russo G; Kant J; Andreef M; Croce CM
Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8907-11. PubMed ID: 2682665
[TBL] [Abstract][Full Text] [Related]
6. Biologic and molecular characterization of non-Hodgkin's lymphoma.
Gaidano G; Dalla-Favera R
Curr Opin Oncol; 1993 Sep; 5(5):776-84. PubMed ID: 8218489
[TBL] [Abstract][Full Text] [Related]
7. [Epstein-Barr virus and Burkitt's lymphoma].
Joab I
Med Trop (Mars); 1999; 59(4 Pt 2):499-502. PubMed ID: 10901854
[TBL] [Abstract][Full Text] [Related]
8. Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas.
Bertrand P; Bastard C; Maingonnat C; Jardin F; Maisonneuve C; Courel MN; Ruminy P; Picquenot JM; Tilly H
Leukemia; 2007 Mar; 21(3):515-23. PubMed ID: 17230227
[TBL] [Abstract][Full Text] [Related]
9. Histogenetic correlations between subcategories of small noncleaved cell lymphomas.
Yano T; van Krieken JH; Magrath IT; Longo DL; Jaffe ES; Raffeld M
Blood; 1992 Mar; 79(5):1282-90. PubMed ID: 1311213
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic rearrangement of C-MYC oncogene occurs prior to infection with Epstein-Barr virus in the monoclonal malignant B cells from an AIDS patient.
Roncella S; Di Celle PF; Cutrona G; Carbone A; Sessarego M; Landonio G; Foà R; Rowe M; Ferrarini M
Leuk Lymphoma; 1993 Jan; 9(1-2):157-64. PubMed ID: 8386576
[TBL] [Abstract][Full Text] [Related]
11. A unique EBV-negative low-grade lymphoma line (WSU-FSCCL) exhibiting both t(14;18) and t(8;11).
Mohammad RM; Mohamed AN; Smith MR; Jawadi NS; al-Katib A
Cancer Genet Cytogenet; 1993 Oct; 70(1):62-7. PubMed ID: 8221615
[TBL] [Abstract][Full Text] [Related]
12. t(8;14;18): a 3-way chromosome translocation in two patients with Burkitt's lymphoma/leukemia.
Liu D; Shimonov J; Primanneni S; Lai Y; Ahmed T; Seiter K
Mol Cancer; 2007 Jun; 6():35. PubMed ID: 17547754
[TBL] [Abstract][Full Text] [Related]
13. t(2;18) and t(18;22) variant chromosomal translocations and bcl-2 gene rearrangements in human malignant lymphomas.
Larsen CJ; Mecucci C; Leroux D
Nouv Rev Fr Hematol (1978); 1990; 32(6):401-3. PubMed ID: 2129304
[TBL] [Abstract][Full Text] [Related]
14. Incidence of Epstein-Barr virus bcl-2 expression and chromosomal translocation t(14;18) in large cell lymphoma associated with paragranuloma (lymphocyte-predominant Hodgkin's disease).
Hansmann ML; Shibata D; Lorenzen J; Hell K; Nathwani BN; Fischer R
Hum Pathol; 1994 Mar; 25(3):240-3. PubMed ID: 8150454
[TBL] [Abstract][Full Text] [Related]
15. [Detection of translocation t(8;14)(q24;132) in pediatric Burkitt's lymphomas using "long distance" polymerase chain reaction: a new method for diagnosis of Burkitt's lymphomas].
zur Stadt U; Reiter A; Welte K; Sykora KW
Klin Padiatr; 1997; 209(4):165-71. PubMed ID: 9340426
[TBL] [Abstract][Full Text] [Related]
16. Molecular epidemiology of Burkitt's lymphoma from South America: differences in breakpoint location and Epstein-Barr virus association from tumors in other world regions.
Gutiérrez MI; Bhatia K; Barriga F; Diez B; Muriel FS; de Andreas ML; Epelman S; Risueño C; Magrath IT
Blood; 1992 Jun; 79(12):3261-6. PubMed ID: 1317726
[TBL] [Abstract][Full Text] [Related]
17. The bcl-2 oncogene in Hodgkin's disease arising in the setting of follicular non-Hodgkin's lymphoma.
LeBrun DP; Ngan BY; Weiss LM; Huie P; Warnke RA; Cleary ML
Blood; 1994 Jan; 83(1):223-30. PubMed ID: 8274737
[TBL] [Abstract][Full Text] [Related]
18. The t(8;14) breakpoint of the EW 36 undifferentiated lymphoma cell line lies 5' of MYC in a region prone to involvement in endemic Burkitt's lymphomas.
Haluska FG; Tsujimoto Y; Croce CM
Nucleic Acids Res; 1988 Mar; 16(5):2077-85. PubMed ID: 3128772
[TBL] [Abstract][Full Text] [Related]
19. Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma.
Lee JT; Innes DJ; Williams ME
J Clin Invest; 1989 Nov; 84(5):1454-9. PubMed ID: 2509518
[TBL] [Abstract][Full Text] [Related]
20. [Molecular analysis in Argentinian patients with Burkitt's lymphoma].
Gutiérrez MI; Barriga F; Díez B; Larripa I; Magrath I
Sangre (Barc); 1990 Feb; 35(1):10-4. PubMed ID: 2159189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
